The FDA reportedly rejected the brain implant company's first human trial approval bid, but the billionaire's biotech venture has kept trying.
To Reuters, however, a director from the Arizona treatment and research center said that Barrow would be well-equipped to conduct brain implant research along the lines of what Neuralink is hoping to do., and a deal is not guaranteed. Reuters’ anonymous sources reportedly said Barrow isn’t the only institute that Neuralink has been in talks with.
Previously, Neuralink was partnered with University of California, Davis for non-human research. Specifically, the biotech company conducted work at UC Davis’ California National Primate Research Center. However, the university ended that partnership for undisclosed reasons in 2020, according toNeuralink is currently facing two federal probes. The first, from the U.S.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Elon Musk tells employees to get back in office with 2:30 am memoMusk is not a fan of remote work. Back in November, he ended Twitter's work-from-home accommodations.
Read more »
Elon Musk Reportedly Tried to Take Over OpenAI Several Years Ago, But FailedElon Musk reportedly tried to takeover as OpenAI's CEO back in 2018. But when the rest of the company's board allegedly vetoed his proposal, he walked away.
Read more »
Elon Musk puts $20 billion value on Twitter, The Information reportsTwitter Inc CEO Elon Musk has offered the social-media company's employees stock grants at a valuation of nearly $20 billion, the Information reported on Saturday, citing a person familiar with an email Musk sent to Twitter staff.
Read more »
Elon Musk concedes Twitter is worth less than half what he paid: reportElon Musk concedes Twitter is now worth less than half what he paid in email about stock grants, report says
Read more »
Elon Musk values Twitter '$20 billion' after $44 billion acquisition in 2022Elon Musk, the CEO of Twitter, has reportedly issued stock grants to the company's staff at a valuation of close to $20 billion, according to multiple media reports on Saturday.
Read more »